Small molecule modulators of telomerase as novel treatments for dyskeratosis congenita
Awardee: Suneet Agarwal
Institution: Boston Children's Hospital
Award Amount: $100,373
Funding Period: February 1, 2019 - January 31, 2020
Previous
Previous
Anti-resorptive drugs in Fibrous Dysplasia of bone: studies on the effects of a RANKL inhibitor and Zoledronic Acid in a murine model of the disease by radiography, histology
Next
Next